MedCity News

Trump’s $500 ACA Refunds: ‘We Shouldn’t Confuse a Check With a Healthcare Affordability Strategy’

North Immunology Reverse Merger Comes With $180M for Next-Gen Inflammation Drug

North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixent.

By Frank Vinluan

Health Tech, Startups

Conceptual image of a pink piggy bank on a dark blue background encircled by various glowing holographic bar graph and line graph displays, symbolizing the integration of big data and financial technology into personal savings. This horizontal composition illustrates the power of analyzing market trends and using a progress indicator to achieve long-term prosperity and investment success. It explores themes of financial literacy and the digital transformation of banking, where augmented reality tools provide a heads up display for monitoring a return on investment. The visual narrative emphasizes the importance of accuracy and business strategy in modern wealth management, showing how digital marketing and information equipment can empower a business person or consumer to make informed decisions for their home finances and future security.

How a Cancer Diagnosis Shaped This VC’s Precision Health Thesis

After a near-miss with her own breast cancer diagnosis, Ariel Ganz co-founded Arben Ventures, a precision health and longevity fund that has backed 83 early-stage startups in three years.

By Katie Adams

MedCity Influencers

The Missing Link in Surgical Safety: Integrating Patient Warming and Positioning

Historically, warming and positioning have been addressed independently because, in many surgical procedures, they do not significantly interfere with one another. However, that’s not the case in most robotic-assisted surgeries.

By Melissa Kelly

Latest Video

Latest News

BioPharma, Pharma

Novartis Gains a Way to Get Drugs Into the Brain, Buying Sironax Tech for $125M

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective blood-brain barrier. The deal comes as Novartis weathers several pipeline setbacks, including trial failures for neuroscience drug candidates.

By Frank Vinluan

Hospitals, Policy, Payers, Providers

As MA Denial Rates Rise, Hospitals Are Betting on Traditional Medicare Instead

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional Medicare. Pearl Health CEO Michael Kopko thinks the original Medicare Advantage bargain has broken down — and that the model may never have been as efficient as policymakers assumed.

By Katie Adams

MedCity Influencers

AI Isn’t a Therapist, but Many Teens Are Treating It Like One

Clinicians have a responsibility to understand the risks posed by AI chatbots and to inform teen patients, their parents and caregivers about them.

By Nikhil Nadkarni

Hospitals, Providers

Pink piggy bank is tightened by a rope on wooden table. Illustration of the concept of budget tightening and reduction of spending

Hospital Margins Fell This Summer Amid Outpatient Slowdown, Data Shows

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall. The margin decrease was driven largely by a seasonal slowdown in elective surgeries and payer mix pressures.

By Katie Adams

Health Tech

Thatch Secures $108M, Reaches $1B Valuation

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.

By Marissa Plescia

BioPharma, Pharma

GSK Commits $750M to Get Chimagen’s Phase 1-Ready Drug for Multiple Myeloma

GSK is acquiring global rights to a T cell engager that Chimagen Biosciences developed to hit three targets. GSK believes this tri-specific approach could offer advantages over currently available drugs that hit two targets, but other big pharma companies are also developing trispecific antibodies.

By Frank Vinluan

MedCity Influencers

The Real Bottleneck in U.S. Pharma Reshoring Isn’t Factories – It’s Talent

Pharma leaders must take a “construction crew” mindset and start treating workforce development in the same manner as they do critical infrastructure.

By Carolyn Durham

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

Health Tech

Nara Health Secures $14M for Third Party Administration Platform

Nara Health’s funding was led by Khosla Ventures, with participation from Long Journey Ventures and Superior Studios.

By Marissa Plescia

BioPharma, Pharma

Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease

Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that directly targets muscle tissue. Isembyld is the first commercial product for Scholar Rock, which is also evaluating the antibody in other rare muscle disorders.

By Frank Vinluan

MedCity Influencers

A human hand interacts with an artificial intelligence robotic hand with medical icons and a digital interface on dark background, illustrating healthcare technology AI trust

Shadow AI Is the Fastest Growing Force in Medicine, and Hospitals Are the Only Ones Who Can Control It

If trust, transparency, and accountability remain core values in medicine, AI governance cannot be left to improvisation.

By Deepthi Bathina

Health Tech

Interra Health Adds GLP-1 Bridge Program Support

Interra Health is helping Medicare patients access $50-per-month GLP-1s through the new Bridge program.

By Marissa Plescia

Artificial Intelligence, Startups, Health Tech

Senior woman using smartphone at kitchen table

Inspiren Rakes In $70M to Scale Its AI-Powered Senior Living Platform

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView Capital. The platform uses ambient sensors and computer vision to predict falls before they happen.

By Katie Adams

MedCity Influencers

Healthcare Needs Software That Handles a Messy Reality

The problem is not that companies have failed to make easy-to-use applications. Rather, it’s that there have been limitations to what software can realistically do in a modern healthcare environment.

By Venky Chellappa